User menu

The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.

Bibliographic reference Dummer, Reinhard ; Guminski, Alexander ; Gutzmer, Ralf ; Dirix, Luc ; Lewis, Karl D ; et. al. The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.. In: Journal of the American academy of dermatology, Vol. 75, no.1, p. 113-125.e5 (2016)
Permanent URL http://hdl.handle.net/2078.1/184910